Underneath the 2019 Modification, contemporary drugs formulated with cannabis, hemp extract, or other cannabinoids needed regulatory assessment and licensing from the Thai FDA underneath the Drug Act with one of the prerequisite disorders remaining the cannabis has to be developed in Thailand.